Showing 19,081 - 19,100 results of 38,854 for search '(( significant decrease decrease ) OR ( significantly ((high disease) OR (slight decrease)) ))', query time: 0.78s Refine Results
  1. 19081
  2. 19082
  3. 19083
  4. 19084
  5. 19085
  6. 19086
  7. 19087
  8. 19088
  9. 19089
  10. 19090
  11. 19091

    Data Sheet 1_Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020.xlsx by Bo Yang (104813)

    Published 2025
    “…Introduction<p>Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide, with liver fibrosis (LF) being a crucial pathological feature in the progression of NAFLD. …”
  12. 19092

    Supplementary file 1_Effect of intravitreal VEGF inhibitors on renal-related adverse events in patients with diabetes mellitus: systematic review and meta-analysis.docx by Yu Zheng (2950)

    Published 2025
    “…Subgroup analyses of AKI incidence stratified by VEGFis types, injection numbers, and treatment duration showed similar event rates across all subgroups, with no statistically significant differences observed.</p>Conclusion<p>Current evidence does not indicate a clear increase in the risk of AKI or CKD with intravitreal VEGFis in adults with DM, but the certainty is very low, and high-risk subgroups remain insufficiently studied.…”
  13. 19093
  14. 19094
  15. 19095
  16. 19096
  17. 19097
  18. 19098
  19. 19099
  20. 19100